Sales for the quarter ended at MNOK 74.1 (MNOK 74.4). There was an increase of 5.7 % in number of procedures in USA, but sales in USA decreased with 6.3 % due to foreign exchange.
Currency neutral sales of own products decreased with 2.7 %. Operating profit (EBIT) ended at MNOK 13.6 (MNOK 16.0). Medistims equipment received an updated recommendation by NICE in UK. Data collection in the REQUEST study was completed, and the first results will be presented at AATS in May. The General Meeting decided to pay a dividend of NOK 2.00 per share (NOK 1.75 per share). Read the full report and financial presentation below.